Atlas Trials

Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises

Clinical trial NCT02573714 · UNKNOWN

Trial details

NCT number
NCT02573714
Sponsor
Cameroon Baptist Convention Health
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2015-12-01
Primary completion
2019-07-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.